Gema Parlange Iturmendi

Gema Parlange Iturmendi is an experienced professional in commercial development and consulting within the pharmaceutical and healthcare sectors. Currently serving as the Chief Commercial and Development Officer at Lumanity, Gema has held prominent roles such as Chief Development Officer for Arsenal Capital Partners' new Value Demonstration Platform and Senior Advisor for Arsenal Capital Partners. Prior to these positions, Gema was the Vice-President and Worldwide Head of PAREXEL Access Consulting at PAREXEL and held multiple leadership roles at IMS Health, including Vice President of Commercial Technology, Global Market Insights, and Global Pharma Development. Gema's educational background includes studies at the University of Deusto and Aix-Marseille University, where advanced academic pursuits are ongoing.